5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis*
References (15)
- et al.
Sulphasalazine and salicylazosulphadimidine in ulcerative colitis
Lancet
(1962) - et al.
Treatment of ulcerative colitis with oral 5 amino salicylic acid in patients unable to take sulphasalazine
Lancet
(1983) - et al.
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine
Gut
(1973) Salazyopyrin, a new sulfanilamide preparation
Acta Med Scand
(1942)- et al.
An experiment to determine the active therapeutic moiety of sulphasalazine
Lancet
(1977) - et al.
Colonic release of 5-aminosalicylic acid from an oral preparation in active ulcerative colitis
Br J Clin Pharmacol
(1983) - et al.
Maintenance or remission in ulcerative colitis with oral preparation of 5 amino salicylic acid
Br Med J
(1982)
There are more references available in the full text version of this article.
Cited by (632)
Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials
2022, Clinical Gastroenterology and HepatologyOutcomes of dietary management approaches in active ulcerative colitis: A systematic review
2022, Clinical NutritionmiR-30c affects the pathogenesis of ulcerative colitis by regulating target gene VIP
2024, Scientific ReportsThe assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis
2024, Alimentary Pharmacology and TherapeuticsCirculating and intestinal regulatory T cells in inflammatory bowel disease: A systemic review and meta-analysis
2024, International Reviews of ImmunologyCorrelation of ex vivo cytokine secretion profiles with scoring indices in ulcerative colitis
2023, European Journal of Clinical Investigation
- *
This work was sponsored by Reid-Rowell Inc., Baudette, Minnesota, and Interfalk Canada, Beloil, PQ, Canada.
Copyright © 1987 Published by Elsevier Inc.